FINTEPLA® (fenfluramine) Oral Solution Now FDA Approved

FINTEPLA® has demonstrated efficacy in the most difficult-to-treat seizure types,1,2 including drop seizures, which cause a person to suddenly lose muscle...

Related Keywords

Japan , United States , Brussels , Bruxelles Capitale , Belgium , France , Smyrna , Izmir , Turkey , French , American , Tracy Dixon Salazar , Mike Davis , Erica Puntel , Nick Francis , Minneap Minn , Antje Witte , Laurent Schots , Twitter , American Epilepsy Society , Ucb Inc , Zogenix Inc , Program See Boxed Warning , Group Of Companies , Zogenix Press , Major Concerns , Guideline Development , Corporate Communications , European Medicines Agency , Lennox Gastaut Syndrome Foundation , Source Ucb Inc , Clinical Global Impressions , Global Epilepsy , Executive Director , Prescribing Information , Boxed Warning , Heart Disease , Pulmonary Arterial Hypertension , Mitigation Strategy , Decreased Weight , Antiepileptic Drugs , Blood Pressure , Euronext Brussels , Gastaut Syndrome , Treatment Landscape , Lennox Gastaut Syndrome , Implementation Subcommittee , American Academy , American Epilepsy , Zogenix Submits New Drug Application , Epileptic Seizures Associated , Zogenix Submits Type , Seizures Associated , Ucb , Nc , Health Care Amp Hospitals , Medical Pharmaceuticals , Pharmaceuticals , Mental Health , Fda Approval ,